Fitostimoline® Hydrogel Versus Saline Gauze Dressing in Diabetic Foot Ulcers
Launched by FEDERICO II UNIVERSITY · Dec 19, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type 1 diabetes and type 2 diabetes,
- • adult patients with DFUs at Grades IC or IIC for a period of at least 12 weeks,
- • an akle brachial index \>0.8,
- • be able to understand simple instructions,
- • provided voluntary, signed informed consent
- Exclusion Criteria:
- • active infection
- • evidence of ischaemia in the limb,
- • osteomyelitis,
- • gangrene,
- • systemic inflammatory or autoimmune disease,
- • use of corticosteroids, immunosuppressive agents, radiation therapy and chemotherapyan,
- • known hypersensitivity to any of the dressing components.
About Federico Ii University
Federico II University, located in Naples, Italy, is a prestigious academic institution with a strong emphasis on advanced research and clinical innovation. As a clinical trial sponsor, the university is committed to fostering the development of novel therapeutic interventions and enhancing patient care through rigorous scientific inquiry. With a multidisciplinary approach, Federico II University collaborates with healthcare professionals, researchers, and industry partners to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its dedication to improving health outcomes is reflected in its robust research programs and commitment to translating scientific findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, , Italy
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials